New ideas, old problems? Heated tobacco products – A systematic review

International Journal of Occupational Medicine and Environmental Health

Volumn 32, Issue 5, 2019, Pages 595-634

  Jankowski, Mateusz ^b   Brożek, Grzegorz M ^b   Lawson, Joshua ^a   Skoczyński, Szymon ^b   Majek, Paulina ^b   Zejda, Jan E ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Heat not burn tobacco products; Heated tobacco products; Nicotine; Smoking; Systematic review; Tobacco industry

Indexed keywords

NICOTINE;

ADVERSE EVENT; AEROSOL; ANIMAL; CHEMISTRY; HEAT; HUMAN; SMOKE; TOBACCO; TOXICITY;

AEROSOLS; ANIMALS; HOT TEMPERATURE; HUMANS; NICOTINE; SMOKE; TOBACCO PRODUCTS;

EID: 85073577193     PISSN: 12321087     EISSN: 1896494X     Source Type: Journal    
DOI: 10.13075/ijomeh.1896.01433     Document Type: Review

References (105)

1. Caputi TL. Industry watch: heat-not-burn tobacco products are about to reach their boiling point. Tob Control. 2016;26(5): 609–10, https://doi.org/10.1136/tobaccocontrol-2016-053264.
2. Liu X, Lugo A, Spizzichino L, Tabuchi T, Gorini G, Gallus S. Heat-Not-Burn Tobacco Products Are Getting Hot in Italy. J Epidemiol. 2018;28(5):274–5, https://doi.org/10.2188/jea.JE 20180040.
3. Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat-not-burn tobacco products: concerns from the Italian experience. Tob Control. 2019;28(1):113–4, https://doi.org/10.1136/tobaccocontrol-2017-054054.
4. Kim M. Philip Morris International introduces new heat-not-burn product, IQOS, in South Korea. Tob Control. 2018;27(e1):e76–8, https://doi.org/10.1136/tobaccocontrol-2017-053965.
5. Tabuchi T, Kiyohara K, Hoshino T, Bekki K, Inaba Y, Kunugita N. Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan. Addiction. 2016;111(4):706–13, https://doi.org/10.1111/add.13231.
6. Tabuchi T, Gallus S, Shinozaki T, Nakaya T, Kunugita N, Col-well B. Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tob Control. 2018;27(e1):e25–33, https://doi.org/10.1136/tobaccocontrol-2017-053947.
7. Uchiyama S, Noguchi M, Takagi N, Hayashida H, Inaba Y, Ogura H, et al. Simple Determination of Gaseous and Particulate Compounds Generated from Heated Tobacco Products. Chem Res Toxicol. 2018;31(7):585–93, https://doi.org/10.1021/acs.chemrestox.8b00024.
8. Davis B, Williams M, Talbot P. iQOS: evidence of pyrolysis and release of a toxicant from plastic. Tob Control. 2019;28(1): 34–41, https://doi.org/10.1136/tobaccocontrol-2017-054104.
9. Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K. Nicotine Delivery to the Aerosol of a Heat-Not-Burn Tobacco Product: Comparison With a Tobacco Cigarette and E-Cigarettes. Nicotine Tob Res. 2018;20(8):1004–9, https://doi.org/10.1093/ntr/ntx138.
10. Proctor C. Assessment of tobacco heating product THP1.0. Part 1: Series introduction. Regul Toxicol Pharmacol. 2018; 93:1–3, https://doi.org/10.1016/j.yrtph.2017.09.010.
11. Eaton D, Jakaj B, Forster M, Nicol J, Mavropoulou E, Scott K, et al. Assessment of tobacco heating product THP1.0. Part 2: Product design, operation and thermophysi-cal characterisation. Regul Toxicol Pharmacol. 2018;93:4–13, https://doi.org/10.1016/j.yrtph.2017.09.009.
12. Yuki D, Sakaguchi C, Kikuchi A, Futamura Y. Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapor product. Regul Toxicol Pharmacol. 2017;87:30–5, https://doi.org/10.1016/j.yrtph.2017.05.005.
13. Ichitsubo H, Kotaki M. Indoor air quality (IAQ) evaluation of a Novel Tobacco Vapor (NTV) product. Regul Toxicol Pharmacol. 2018;92:278–94, https://doi.org/10.1016/j.yrtph.2017.12.017.
14. Mitova MI, Campelos PB, Goujon-Ginglinger CG, Maeder S, Mottier N, Rouget EG, et al. Comparison of the impact of the Tobacco Heating System 2.2 and a cigarette on indoor air quality. Regul Toxicol Pharmacol. 2016;80:91–101, https://doi.org/10.1016/j.yrtph.2016.06.005.
15. Jaccard G, Tafin Djoko D, Moennikes O, Jeannet C, Kondylis A, Belushkin M. Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes. Regul Toxicol Pharmacol. 2017;90:1–8, https://doi.org/10.1016/j.yrtph.2017.08.006.
16. Haswell LE, Corke S, Verrastro I, Baxter A, Banerjee A, Adamson J, et al. In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke. Sci Rep. 2018;8(1):1145, https://doi.org/10.1038/s41598-018-19627-0.
17. Crooks I, Neilson L, Scott K, Reynolds L, Oke T, Forster M, et al. Evaluation of flavourings potentially used in a heated tobacco product: Chemical analysis, in vitro mutagenicity, genotoxicity, cytotoxicity and in vitro tumour promoting activity. Food Chem Toxicol. 2018;118:940–52, https://doi.org/10.1016/j.fct.2018.05.058.
18. Ishikawa S, Matsumura K, Kitamura N, Ishimori K, Takanami Y, Ito S. Application of a direct aerosol exposure system for the assessment of biological effects of cigarette smoke and novel tobacco product vapor on human bronchial epithelial cultures. Regul Toxicol Pharmacol. 2018;96:85–93, https://doi.org/10.1016/j.yrtph.2018.05.004.
19. Phillips BW, Schlage WK, Titz B, Kogel U, Sciuscio D, Martin F, et al. A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathology. Food Chem Toxicol. 2018;116:388–413, https://doi.org/10.1016/j.fct.2018.04.015.
20. Pacitto A, Stabile L, Scungio M, Rizza V, Buonanno G. Characterization of airborne particles emitted by an electrically heated tobacco smoking system. Environ Pollut. 2018;240: 248–54, https://doi.org/10.1016/j.envpol.2018.04.137.
21. Bekki K, Inaba Y, Uchiyama S, Kunugita N. Comparison of Chemicals in Mainstream Smoke in Heat-not-burn Tobacco and Combustion Cigarettes. J UOEH. 2017;39(3):201–7, https://doi.org/10.7888/juoeh.39.201.
22. Smith MR, Clark B, Lüdicke F, Schaller JP, Vanscheeuwijck P, Hoeng J, et al. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program. Regul Toxicol Pharmacol. 2016;81: S17–26, https://doi.org/10.1016/j.yrtph.2016.07.006.
23. Pratte P, Cosandey S, Goujon Ginglinger C. Investigation of solid particles in the mainstream aerosol of the Tobacco Heating System THS2.2 and mainstream smoke of a 3R4F reference cigarette. Hum Exp Toxicol. 2017;36(11):1115–20, https://doi.org/10.1177/0960327116681653.
24. Buratto R, Correia D, Parel M, Crenna M, Bilger M, Debrick A. Determination of eight carbonyl compounds in aerosols trapped in phosphate buffer saline solutions to support in vitro assessment studies. Talanta. 2018;184:42–9, https://doi.org/10.1016/j.talanta.2018.02.048.
25. Protano C, Manigrasso M, Avino P, Sernia S, Vitali M. Second-hand smoke exposure generated by new electronic devices (IQOS® and e-cigs) and traditional cigarettes: sub-micron particle behaviour in human respiratory system. Ann Ig. 2016;28(2):109–12, https://doi.org/10.7416/ai.2016.2089.
26. Protano C, Manigrasso M, Avino P, Vitali M. Second-hand smoke generated by combustion and electronic smoking devices used in real scenarios: Ultrafine particle pollution and age-related dose assessment. Environ Int. 2017;107:190–5, https://doi.org/10.1016/j.envint.2017.07.014.
27. Li X, Luo Y, Jiang X, Zhang H, Zhu F, Hu S, et al. Chemical Analysis and Simulated Pyrolysis of Tobacco Heating System 2.2 Compared to Conventional Cigarettes. Nicotine Tob Res. 2019;21(1):111–8, https://doi.org/10.1093/ntr/nty005.
28. Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K, Leischow SJ. Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Addiction. 2018;113(11):2099–106, https://doi.org/10.1111/add.14365.
29. Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name. JAMA Intern Med. 2017;177(7):1050–2, https://doi.org/10.1001/jamainternmed.2017.1419.
30. Auer R, Cornuz J, Berthet A. Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes-Reply. JAMA Intern Med. 2017;177(11):1699–700, https://doi.org/10.1001/jamainternmed.2017.5861.
31. Caruso M, Polosa R. Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes. JAMA Intern Med. 2017;177(11):1699, https://doi.org/10.1001/jamainternmed.2017.5843.
32. Maeder S, Peitsch MC. Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes. JAMA Intern Med. 2017;177(11):1698–9, https://doi.org/10.1001/jamaintern med.2017.5840.
33. Mallock N, Böss L, Burk R, Danziger M, Welsch T, Hahn H, et al. Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks. Arch Toxicol. 2018;92(6):2145–9, https://doi.org/10.1007/s00204-018-2215-y.
34. Ruprecht AA, De Marco C, Saffari A, Pozzi P, Mazza R, Veronese C, et al. Environmental pollution and emission factors of electronic cigarettes, heat-not-burn tobacco products, and conventional cigarettes. Aerosol Sci Technol. 2017;51:(6):674–84, https://doi.org/10.1080/02786826.2017. 1300231.
35. Ruprecht AA, De Marco C, Saffari A, Pozzi P, Mazza R, Veronese C, et al. Erratum to: Environmental pollution and emission factors of electronic cigarettes, heat-not-burn tobacco products, and conventional cigarettes. Aerosol Sci Technol. 2017;51:(11):1332, https://doi.org/10.1080/02786826.2017.1397236.
36. Brossard P, Weitkunat R, Poux V, Lama N, Haziza C, Picavet P, et al. Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers. Regul Toxicol Pharmacol. 2017;89:193–9, https://doi.org/10.1016/j.yrtph.2017.07.032.
37. Leigh NJ, Palumbo MN, Marino AM, O’Connor RJ, Goniewicz ML. Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS. Tob Control. 2018;27(Sup-pl 1):s37–8, https://doi.org/10.1136/tobaccocontrol-2018-05 4318.
38. Salman R, Talih S, El-Hage R, Haddad C, Karaoghlanian N, El-Hellani A, et al. Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product. Nicotine Tob Res. 2018, https://doi.org/10.1093/ntr/nty235.
39. Dayan AD. Investigating a toxic risk (self-inflicted) the example of conventional and advanced studies of a novel Tobacco Heating System. Regul Toxicol Pharmacol. 2016;81:S15–6, https://doi.org/10.1016/j.yrtph.2016.07.020.
40. Schaller JP, Keller D, Poget L, Pratte P, Kaelin E, McHugh D, et al. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016;81:S27–47, https://doi.org/10.1016/j.yrtph.2016.10.001.
41. Schaller JP, Pijnenburg JP, Ajithkumar A, Tricker AR. Evaluation of the Tobacco Heating System 2.2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2.2 aerosol. Regul Toxicol Pharmacol. 2016;81:S48–58, https://doi.org/10.1016/j.yrtph.2016.10.016.
42. Wong ET, Kogel U, Veljkovic E, Martin F, Xiang Y, Boue S, et al. Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharmacol. 2016;81:S59–81, https://doi.org/10.1016/j.yrtph.2016.10.015.
43. Sewer A, Kogel U, Talikka M, Wong ET, Martin F, Xiang Y, et al. Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. Regul Toxicol Pharmacol. 2016;81:S82–92, https://doi.org/10.1016/j.yrtph.2016.11.018.
44. Oviedo A, Lebrun S, Kogel U, Ho J, Tan WT, Titz B, et al. Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharmacol. 2016;81:S93–122, https://doi.org/10.1016/j.yrtph.2016.11.004.
45. Kogel U, Titz B, Schlage WK, Nury C, Martin F, Oviedo A, et al. Evaluation of the Tobacco Heating System 2.2. Part 7: Systems toxicological assessment of a mentholated version revealed reduced cellular and molecular exposure effects compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharmacol. 2016;81:S123–38, https://doi.org/10.1016/j.yrtph.2016.11.001.
46. Haziza C, de La Bourdonnaye G, Skiada D, Ancerewicz J, Baker G, Picavet P, et al. Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharmacol. 2016;81:S139–50, https://doi.org/10.1016/j.yrtph.2016.11.003.
47. Martin F, Talikka M, Ivanov NV, Haziza C, Hoeng J, Peitsch MC. Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2. Regul Toxicol Pharmacol. 2016;81:S151–7, https://doi.org/10.1016/j.yrtph.2016.11.011.
48. Forster M, Fiebelkorn S, Yurteri C, Mariner D, Liu C, Wright C, et al. Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions. Regul Toxicol Pharmacol. 2018;93:14–33, https://doi.org/10.1016/j.yrtph.2017.10.006.
49. Forster M, McAughey J, Prasad K, Mavropoulou E, Proctor C. Assessment of tobacco heating product THP1.0. Part 4: Characterisation of indoor air quality and odour. Regul Toxicol Pharmacol. 2018;93:34–51, https://doi.org/10.1016/j.yrtph.2017.09.017.
50. Jaunky T, Adamson J, Santopietro S, Terry A, Thorne D, Breheny D, et al. Assessment of tobacco heating product THP1.0. Part 5: In vitro dosimetric and cytotoxic assessment. Regul Toxicol Pharmacol. 2018;93:52–61, https://doi.org/10.1016/j.yrtph.2017.09.016.
51. Taylor M, Thorne D, Carr T, Breheny D, Walker P, Proctor C, et al. Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches. Regul Toxicol Pharmacol. 2018;93:62–70, https://doi.org/10.1016/j.yrtph.2017.08.016.
52. Thorne D, Breheny D, Proctor C, Gaca M. Assessment of novel tobacco heating product THP1.0. Part 7: Comparative in vitro toxicological evaluation. Regul Toxicol Pharmacol. 2018;93:71–83, https://doi.org/10.1016/j.yrtph.2017.08.017.
53. Gee J, Prasad K, Slayford S, Gray A, Nother K, Cunningham A, et al. Assessment of tobacco heating product THP1.0. Part 8: Study to determine puffing topography, mouth level exposure and consumption among Japanese users. Regul Toxicol Pharmacol. 2018;93:84–91, https://doi.org/10.1016/j.yrtph.2017.08.005.
54. Murphy J, Liu C, McAdam K, Gaça M, Prasad K, Camacho O, et al. Assessment of tobacco heating product THP1.0. Part 9: The placement of a range of next-generation products on an emissions continuum relative to cigarettes via pre-clinical assessment studies. Regul Toxicol Pharmacol. 2018;93:92–104, https://doi.org/10.1016/j.yrtph.2017.10.001.
55. Poussin C, Laurent A, Peitsch MC, Hoeng J, De Leon H. Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells. Toxicology. 2016;339:73–86, https://doi.org/10.1016/j.tox.2015.11.007.
56. Van der Toorn M, Frentzel S, De Leon H, Goedertier D, Peitsch MC, Hoeng J. Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes. Food Chem Toxicol. 2015;86:81–7, https://doi.org/10.1016/j.fct.2015.09.016.
57. Iskandar AR, Mathis C, Schlage WK, Frentzel S, Leroy P, Xiang Y, et al. A systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures. Toxicol In Vitro. 2017;39:29–51, https://doi.org/10.1016/j.tiv.2016.11.009.
58. Iskandar AR, Mathis C, Martin F, Leroy P, Sewer A, Majeed S, et al. 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product. ALTEX. 2017;34(1):23–48, https://doi.org/10.14573/altex. 1605041.
59. Zanetti F, Titz B, Sewer A, Lo Sasso G, Scotti E, Schlage WK, et al. Comparative systems toxicology analysis of cigarette smoke and aerosol from a candidate modified risk tobacco product in organotypic human gingival epithelial cultures: A 3-day repeated exposure study. Food Chem Toxicol. 2017;101:15–35, https://doi.org/10.1016/j.fct.2016.12.027.
60. Zhao X, Zanetti F, Majeed S, Pan J, Malmstrom H, Peitsch MC, et al. Effects of cigarette smoking on color stability of dental resin composites. Am J Dent. 2017;30(6):316–22.
61. Malinska D, Szymański J, Patalas-Krawczyk P, Michalska B, Wojtala A, Prill M, et al. Assessment of mitochondrial function following short- and long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product and reference cigarettes. Food Chem Toxicol. 2018;115:1–12, https://doi.org/10.1016/j.fct.2018.02.013.
62. Van der Toorn M, Sewer A, Marescotti D, Johne S, Baumer K, Bornand D, et al. The biological effects of long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product. Toxicol In Vitro. 2018;50:95–108, https://doi.org/10.1016/j.tiv.2018.02.019.
63. Takahashi Y, Kanemaru Y, Fukushima T, Eguchi K, Yoshida S, Miller-Holt J, et al. Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: A comparison with cigarette smoke. Regul Toxicol Pharmacol. 2018;92:94–103, https://doi.org/10.1016/j.yrtph.2017.11.009.
64. Szostak J, Boué S, Talikka M, Guedj E, Martin F, Phillips B, et al. Aerosol from Tobacco Heating System 2.2 has reduced impact on mouse heart gene expression compared with cigarette smoke. Food Chem Toxicol. 2017;101:157–67, https://doi.org/10.1016/j.fct.2017.01.013.
65. Lo Sasso G, Titz B, Nury C, Boué S, Phillips B, Belcastro V, et al. Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe-/- mice – a systems toxicology analysis. Inhal Toxicol. 2016;28(5):226–40, https://doi.org/10.3109/08958378.2016. 1150368.
66. Phillips B, Veljkovic E, Boué S, Schlage WK, Vuillaume G, Martin F, et al. An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes. Toxicol Sci. 2016;149(2):411–32, https://doi.org/10.1093/toxsci/kfv243.
67. Phillips B, Veljkovic E, Boué S, Schlage WK, Vuillaume G, Martin F, et al. Erratum to: An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes. Toxicol Sci. 2016;151(2):462–4, https://doi.org/10.1093/toxsci/kfw062.
68. Titz B, Boué S, Phillips B, Talikka M, Vihervaara T, Schneider T, et al. Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe-/- Mice-An Integrative Systems Toxicology Analysis. Toxicol Sci. 2016;149(2):441–57, https://doi.org/10.1093/toxsci/kfv244.
69. Velicer C, St Helen G, Glantz SA. Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology. J Public Health Policy. 2018;39(1):34–48, https://doi.org/10.1057/s41271-017-0096-6.
70. Chun L, Moazed F, Matthay M, Calfee C, Gotts J. Possible hepatotoxicity of IQOS. Tob Control. 2018;27(Suppl 1):s39–40, https://doi.org/10.1136/tobaccocontrol-2018-054320.
71. Nabavizadeh P, Liu J, Havel CM, Ibrahim S, Derakhshandeh R, Jacob Iii P, et al. Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control. 2018;27(Suppl 1): s13–9, https://doi.org/10.1136/tobaccocontrol-2018-054325.
72. Leigh NJ, Tran PL, O’Connor RJ, Goniewicz ML. Cytotoxic effects of heated tobacco products (HTP) on human bronchial epithelial cells. Tob Control. 2018;27(Suppl 1):s26–9, https://doi.org/10.1136/tobaccocontrol-2018-054317.
73. Picavet P, Haziza C, Lama N, Weitkunat R, Lüdicke F. Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes. Nicotine Tob Res. 2016;18(5):557–63, https://doi.org/10.1093/ntr/ntv220.
74. Lüdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, et al. Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1). Nicotine Tob Res. 2018;20(2):161–72, https://doi.org/10.1093/ntr/ntw287.
75. Lüdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, et al. Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2). Nicotine Tob Res. 2018;20(2):173–82, https://doi.org/10.1093/ntr/ ntx028.
76. Lüdicke F, Baker G, Magnette J, Picavet P, Weitkunat R. Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1. Nicotine Tob Res. 2017;19(2):168–75, https://doi.org/10.1093/ntr/ntw164.
77. Haziza C, de La Bourdonnaye G, Merlet S, Benzimra M, Ancerewicz J, Donelli A, et al. Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: A randomized controlled study in confinement. Regul Toxicol Pharmacol. 2016;81:489–99, https://doi.org/10.1016/j.yrtph.2016.09.014.
78. Gale N, McEwan M, Eldridge AC, Fearon IM, Sherwood N, Bowen E, et al. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects. Nicotine Tob Res. 2018:1–8, https://doi.org/10.1093/ntr/nty104.
79. Adriaens K, Gucht DV, Baeyens F. IQOSTM vs. e-Cigarette vs. Tobacco Cigarette: A Direct Comparison of Short-Term Effects after Overnight-Abstinence. Int J Environ Res Public Health. 2018;15(12):E2902, https://doi.org/10.3390/ ijerph15122902.
80. Stephens WE. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob Control. 2018;27:10–7, https://doi.org/10.1136/tobaccocontrol-2017-053808.
81. Kamada T, Yamashita T, Tomioka H. Acute eosinophilic pneumonia following heat-not-burn cigarette smoking. Respirol Case Rep. 2016;4(6):e00190, https://doi.org/10.1002/rcr2.190.
82. Aokage T, Tsukahara K, Fukuda Y, Tokioka F, Taniguchi A, Naito H, et al. Heat-not-burn cigarettes induce fulminant acute eosinophilic pneumonia requiring extracorporeal membrane oxygenation. Respir Med Case Rep. 2018;26:87–90, https://doi.org/10.1016/j.rmcr.2018.12.002.
83. Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J. Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tob Control. 2018;27(Suppl 1):s20–5, https://doi.org/10.1136/tobaccocontrol-2018-054296.
84. Glantz SA. PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control. 2018;27(Suppl 1):s9–12, https://doi.org/10.1136/tobaccocontrol-2018-054413.
85. Brose LS, Simonavicius E, Cheeseman H. Awareness and Use of “Heat-not-burn” Tobacco Products in Great Britain. Tob Regul Sci. 2018;4(2):44–50, https://doi.org/10.18001/TRS.4.2.4.
86. Kim J, Yu H, Lee S, Paek YJ. Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adult. Tob Control. 2018;27:s74–7, https://doi.org/10.1136/tobaccocontrol-2018-054390.
87. Nyman AL, Weaver SR, Popova L, Pechacek TF, Huang J, Ashley DL, et al. Awareness and use of heated tobacco products among US adults, 2016-2017. Tob Control. 2018;27(Suppl 1): s55–61, https://doi.org/10.1136/tobaccocontrol-2018-054323.
88. Marynak KL, Wang TW, King BA, Agaku IT, Reimels EA, Graffunder CM. Awareness and Ever Use of “Heat-Not-Burn” Tobacco Products Among U.S. Adults, 2017. Am J Prev Med. 2018;55(4):551–4, https://doi.org/10.1016/j.amepre.2018.04.031.
89. Miyazaki Y, Tabuchi T. Educational gradients in the use of electronic cigarettes and heat-not-burn tobacco products in Japan. PLoS One. 2018;13(1):e0191008, https://doi.org/10.1371/journal.pone.0191008.
90. Caputi TL, Leas E, Dredze M, Cohen JE, Ayers JW. They’re heating up: Internet search query trends reveal significant public interest in heat-not-burn tobacco products. PLoS One. 2017;12(10):e0185735, https://doi.org/10.1371/journal.pone.0185735.
91. Elias J, Dutra LM, St Helen G, Ling PM. Revolution or redux? Assessing IQOS through a precursor product. Tob Control. 2018;27(Suppl 1):s102–10, https://doi.org/10.1136/ tobaccocontrol-2018-054327.
92. Mathers A, Schwartz R, O’Connor S, Fung M, Diemert L. Marketing IQOS in a dark market. Tob Control. 2018;28(2): 237–8, https://doi.org/10.1136/tobaccocontrol-2017-054216.
93. Hair EC, Bennett M, Sheen E, Cantrell J, Briggs J, Fenn Z, et al. Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland. Tob Control. 2018;27(Suppl 1):s70–3, https://doi.org/10.1136/tobaccocontrol-2018-054322.
94. Rosen LJ, Kislev S. IQOS campaign in Israel. Tob Control. 2018;27(Suppl 1):s78–81, https://doi.org/10.1136/tobaccocon trol-2018-054619.
95. Liber AC. Heated tobacco products and combusted cigarettes: comparing global prices and taxes. Tob Control. 2018, https://doi.org/10.1136/tobaccocontrol-2018-054602.
96. Kreitzberg DS, Murthy D, Loukas A, Pasch KE. Heat not burn tobacco promotion on instagram. Addict Behav. 2019;91:112–8, https://doi.org/10.1016/j.addbeh.2018.09.003.
97. Elias J, Ling PM. Invisible smoke: third-party endorsement and the resurrection of heat-not-burn tobacco products. Tob Control. 2018;27(Suppl 1):s96–101, https://doi.org/10.1136/tobaccocontrol-2018-054433.
98. Lempert LK, Glantz SA. Heated tobacco product regulation under US law and the FCTC. Tob Control. 2018;27(Suppl 1):s118–25, https://doi.org/10.1136/tobaccocontrol-2018-054560.
99. World Health Organization [Internet]. Geneva: The Organization; 2018 [cited 2018 Dec 23]. Heated tobacco products (HTPs) information sheet. Available from: http://www.who.int/tobacco/publications/prod_regulation/heated-tobacco-products/en/.
100. European Respiratory Society [Internet]. Lausanne: The Organization; 2018 [cited 2018 Dec 23]. ERS position paper on heated tobacco products. Available from: https://www.ersnet.org/the-society/news/ers-position-paper-onheated-tobacco-products.
101. Public Health England [Internet]. London: The Organization; 2018 [cited 2018 Dec 23]. Evidence review of e-cigarettes and heated tobacco products 2018: executive summary. Available from: https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review/evidence-review-of-e-cigarettes-and-heatedtobacco-products-2018-executive-summary.
102. McKelvey K, Popova L, Kim M, Lempert LK, Chaffee BW, Vijayaraghavan M, et al. IQOS labelling will mislead consumers. Tob Control. 2018;27(Suppl 1):s48–54, https://doi.org/10.1136/tobaccocontrol-2018-054333.
103. Vandewater EA, Clendennen SL, Hébert ET, Bigman G, Jackson CD, Wilkinson AV, et al. Whose Post Is It? Predicting E-cigarette Brand from Social Media Posts. Tob Regul Sci. 2018;4:30–43, https://doi.org/10.18001/TRS.4.2.3.
104. Collins L, Glasser AM, Abudayyeh H, Pearson JL, Villanti AC. E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information. Nicotine Tob Res. 2019;21(1):14–24, https://doi.org/10.1093/ntr/ntx284.
105. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ. 2009;339:b2535, https://www.bmj.com/content/339/bmj.b2535.